公开(公告)号：US20090209503A1

公开(公告)日：2009-08-20

申请号：US12430597

申请日：2009-04-27

申请人： Tomoyuki TAGAMI ,  Tomoyuki TABATA ,  Tsutomu UMEZAWA ,  Yasuo SUZUKI

发明人： Tomoyuki TAGAMI ,  Tomoyuki TABATA ,  Tsutomu UMEZAWA ,  Yasuo SUZUKI

IPC分类号： A61K31/56 ,  A61K31/198 ,  A61P1/00

CPC分类号： A61K31/19 ,  A61K31/198 ,  A61K31/56

摘要： The present invention discloses a therapeutic agent for inflammatory bowel disease, which is in the from of delivering 1 to 5 g of glutamine to the large intestine per one administration; and the therapeutic agent for inflammatory bowel disease with which an anti-inflammatory agent(s) is combined. This therapeutic agent for inflammatory bowel disease can safely and effectively treat inflammatory bowel disease including ulcerative colitis without increasing the frequency of bowel movements.

摘要翻译： 本发明公开了一种用于炎症性肠病的治疗剂，其是每次给药向大肠递送1至5g谷氨酰胺; 和抗炎剂组合的炎症性肠病治疗剂。 这种炎症性肠病治疗剂可以安全有效地治疗包括溃疡性结肠炎在内的炎性肠病，而不增加排便的频率。